Famotidine (Pepcid) is an H2 receptor antagonist that reduces stomach acid by blocking histamine H2 receptors on gastric parietal cells. It is used for heartburn, GERD, and peptic ulcer disease. Available both over-the-counter and by prescription, famotidine is notable for its clean drug interaction profile — unlike cimetidine, it does not significantly inhibit CYP450 enzymes. Onset of action occurs within about one hour. It is generally considered safer for long-term use than proton pump inhibitors.
Famotidine
Uses & FDA Indications
Famotidine is FDA-approved for treatment of active duodenal ulcer, maintenance therapy of duodenal ulcer after healing, treatment of active benign gastric ulcer, gastroesophageal reflux disease (GERD), including erosive esophagitis, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome. Over-the-counter formulations are indicated for heartburn, acid indigestion, and sour stomach.
As an OTC product, Pepcid AC is one of the most widely used acid reducers in the United States. Unlike antacids (calcium carbonate, magnesium hydroxide), which neutralize acid already present, famotidine reduces acid production at its source and provides longer duration of relief — typically 8–12 hours per dose.
Off-label uses include prevention of stress ulcers in critically ill patients, management of urticaria (as an adjunct to H1 antihistamines), and prevention of NSAID-induced ulcers in patients who cannot use proton pump inhibitors.
How It Works
Famotidine competitively and reversibly blocks histamine H2 receptors on the basolateral membrane of gastric parietal cells. Histamine, released by enterochromaffin-like cells in the gastric mucosa, is a primary stimulant of acid secretion — it activates adenylyl cyclase, raising intracellular cAMP and activating the H+/K+-ATPase proton pump. By blocking the H2 receptor, famotidine significantly reduces basal and meal-stimulated acid secretion.
Famotidine is approximately 20–50 times more potent than cimetidine and 3–10 times more potent than ranitidine on a milligram basis. Unlike cimetidine, famotidine does not inhibit hepatic cytochrome P450 enzymes, does not bind androgen receptors (avoiding the gynecomastia and sexual side effects of cimetidine), and does not penetrate the blood-brain barrier to any significant degree.
The H2 blocker class once included ranitidine (Zantac), which was voluntarily withdrawn from the market in 2020 after the FDA found that ranitidine molecules can degrade over time or under certain storage conditions to produce unacceptable levels of N-nitrosodimethylamine (NDMA), a probable human carcinogen. Famotidine does not have this structural liability and remains on the market.
Side Effects
Common
- Headache — reported in a small percentage of patients
- Dizziness
- Constipation or diarrhea
- Nausea — less common than with cimetidine
Serious (Rare)
- Thrombocytopenia — rare reversible decrease in platelet count
- QT prolongation — particularly relevant with IV famotidine; risk is low but increases when combined with other QT-prolonging agents
- Acute interstitial nephritis — rare; can occur with H2 blockers and PPIs
- CNS effects — confusion, agitation, hallucinations reported rarely, particularly in elderly patients or those with renal impairment (famotidine partially excreted renally)
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Atazanavir, Rilpivirine, Dasatinib (pH-sensitive drugs) | Famotidine raises gastric pH, reducing absorption of drugs that require an acidic environment to dissolve. Atazanavir levels can drop significantly, leading to virologic failure. Dasatinib absorption is also substantially reduced. | High — these combinations are contraindicated or require specific timing separation |
| Ketoconazole, Itraconazole (azole antifungals) | Reduced absorption due to elevated gastric pH; these antifungals require acid for adequate dissolution and absorption. | Moderate — avoid concurrent use or use alternative antifungal |
| Cefpodoxime, Cefuroxime (some cephalosporins) | Decreased absorption due to elevated pH. Clinical significance varies by specific cephalosporin. | Low-Moderate — take famotidine well after the antibiotic if possible |
| Antacids | Antacids may reduce famotidine absorption slightly when taken simultaneously; separate by at least 2 hours. | Low — minor timing adjustment recommended |
Warnings & Contraindications
Contraindications
- Known hypersensitivity to famotidine or other H2 receptor antagonists
Renal Impairment
Famotidine is predominantly eliminated by the kidneys. In patients with renal impairment (creatinine clearance below 50 mL/min), accumulation occurs and the risk of CNS side effects (confusion, agitation) increases. Dose adjustment is required in significant renal impairment — prescribers should consult current dosing guidelines for renal dose modifications.
Masking of Serious Conditions
Like all acid-suppressing therapies, famotidine can partially relieve symptoms of serious conditions including gastric cancer and esophageal cancer. Patients with alarm symptoms — unexplained weight loss, dysphagia, persistent vomiting, or gastrointestinal bleeding — should be evaluated thoroughly before starting acid-suppression therapy and should not self-treat with OTC famotidine for extended periods without medical evaluation.
RANITIDINE RECALL NOTE: Ranitidine (Zantac), another H2 blocker, was withdrawn from the U.S. market in April 2020 after FDA found unacceptable levels of NDMA (a probable carcinogen) in both the drug itself and its degradation products. Famotidine does not share ranitidine's structural instability and has not been subject to this type of recall.
Check for interactions between famotidine and your other medications.
Check Drug Interactions →Frequently Asked Questions
What is the difference between famotidine and omeprazole?
Famotidine is an H2 receptor antagonist while omeprazole is a proton pump inhibitor (PPI). Both reduce stomach acid but through different mechanisms. Famotidine blocks histamine receptors on parietal cells, providing faster onset of relief (within 1 hour) but less complete acid suppression. Omeprazole irreversibly blocks the final acid pump, providing more complete and sustained acid suppression but requires 1–4 days to reach full effect. For on-demand heartburn relief, famotidine acts faster; for healing of esophagitis or ulcers, PPIs are generally more effective. Famotidine also has a better long-term safety profile regarding magnesium deficiency and C. difficile risk compared to PPIs.
Can famotidine be taken long-term?
Famotidine is generally considered safe for long-term use at prescribed doses, with a more favorable long-term safety profile than proton pump inhibitors. Unlike PPIs, famotidine is not associated with significant risks of hypomagnesemia, bone density loss, or increased C. difficile infection. However, long-term self-medication for heartburn without medical evaluation may delay diagnosis of conditions such as peptic ulcer disease, Barrett's esophagus, or gastric cancer. Any persistent gastrointestinal symptoms lasting more than two weeks should prompt medical evaluation.
Is famotidine the same as Pepcid AC?
Yes. Pepcid AC is an over-the-counter brand of famotidine used for heartburn and acid indigestion. Prescription Pepcid contains the same active ingredient but is available in higher doses for conditions such as GERD, peptic ulcer disease, and Zollinger-Ellison syndrome. The OTC formulation is identical in mechanism and active ingredient to the prescription version — only the doses differ.